|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01011 NT PHARMA
Nominal 
0.440 +0.080 (+22.222%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (5,389) | (9,066) | 50,476 | 36,210 |
| Net Cash from / (used in) Investing Activities | -- | (152) | (189) | (22,140) | 4,530 |
| Net Cash from / (used in) Financing Activities | -- | 4,871 | 12,653 | (28,972) | (46,676) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (670) | 3,398 | (636) | (5,936) |
| Cash & Cash Equivalents at beginning of period | -- | 9,623 | 1,520 | 1,916 | 4,364 |
| Effect of Foreign Exchange Rate Changes | -- | (1,732) | 4,705 | 240 | 3,488 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 7,221 | 9,623 | 1,520 | 1,916 |
| Remarks: | Real time quote last updated: 24/08/2026 14:28 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -18,433 |
| %Change | 9.032% |
| EPS / (LPS) | RMB -0.022 |
| NBV Per Share (¥) | RMB -0.117 |